GLP-1 Receptor Agonists Show Promise for Treating Extragenital Lichen Sclerosus: A Case Report
By
@shihcheng.bsky.social
4d ago· 3 min readenInsight
80/100
Golden Brown
Bagelometer↗
Sesame, salt, and substance. A flagship bake.
Score80TypeanalysisSentimentpositive
Summary
This case report describes two patients with extragenital lichen sclerosus, a chronic inflammatory skin condition, whose symptoms improved significantly after treatment with glucagon-like peptide-1 (GLP-1) receptor agonists. The findings suggest a potential new therapeutic avenue for this condition, which currently has limited treatment options.
Key quotes
· 2 pulledThis case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor agonists.
The findings suggest a potential new therapeutic avenue for this condition, which currently has limited treatment options.
This case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor agonists.
